Daratumumab-based therapies in patients with AL amyloidosis.

被引：0
|
作者：
Abeykoon, Jithma P.
Zanwar, Saurabh
Kumar, Shaji
Dispenzieri, Angela
Rajkumar, S. Vincent
Lacy, Martha
Dingli, David
Leung, Nelson
Muchtar, Eli
Gonsalves, Wilson I.
Kourelis, Taxiarchis
Buadi, Francis
Kyle, Robert A.
Gertz, Morie A.
Kapoor, Prashant
机构：
[1] Mayo Clin, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.8053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8053
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Outcomes of Patients with AL Amyloidosis after Failure of Daratumumab-Based Therapy
    Theodorakakou, Foteini
    Spiliopoulou, Vasiliki
    Fotiou, Despina
    Roussou, Maria
    Malandrakis, Panagiotis
    Ntanasis-Stathopoulos, Ioannis
    Migkou, Magdalini
    Papaiakovou, Evangelos Eleutherakis
    Kanellias, Nikolaos
    Papanikolaou, Asimina
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios-Athanasios
    Kastritis, Efstathios
    BLOOD, 2022, 140 : 4275 - 4276
  • [2] Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
    Abeykoon, Jithma P.
    Zanwar, Saurabh
    Dispenzieri, Angela
    Gertz, Morie A.
    Leung, Nelson
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Muchtar, Eli
    Dingli, David
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis
    Warsame, Rahma
    Kyle, Robert A.
    Rajkumar, Vincent
    Kumar, Shaji
    Kapoor, Prashant
    LEUKEMIA, 2019, 33 (02) : 531 - 536
  • [3] Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
    Jithma P. Abeykoon
    Saurabh Zanwar
    Angela Dispenzieri
    Morie A. Gertz
    Nelson Leung
    Taxiarchis Kourelis
    Wilson Gonsalves
    Eli Muchtar
    David Dingli
    Martha Q. Lacy
    Suzanne R. Hayman
    Francis Buadi
    Rahma Warsame
    Robert A. Kyle
    Vincent Rajkumar
    Shaji Kumar
    Prashant Kapoor
    Leukemia, 2019, 33 : 531 - 536
  • [4] Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapy
    Theodorakakou, Foteini
    Fotiou, Despina
    Spiliopoulou, Vasiliki
    Roussou, Maria
    Malandrakis, Panagiotis
    Ntanasis-Stathopoulos, Ioannis
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Kanellias, Nikolaos
    Papanikolaou, Asimina
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (03) : 411 - 415
  • [5] Pattern of Use and Efficacy of Daratumumab-Based Therapy in Patients with AL Amyloidosis: A Single Institution Experience
    Dima, Danai
    Hu, Xiao
    Dower, Joshua
    Comenzo, Raymond L.
    Varga, Cindy
    BLOOD, 2020, 136
  • [6] Safety and efficacy of daratumumab-based chemoimmunotherapy in multiple myeloma or AL amyloidosis patients with advanced renal failure
    Landau, Kevin
    Fu, Chieh Lin
    Chaulagain, Chakra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S43 - S43
  • [7] Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study
    Chakraborty, Rajshekhar
    Bhutani, Divaya
    Mapara, Markus
    Reshef, Ran
    Maurer, Mathew S.
    Radhakrishnan, Jai
    Lentzsch, Suzanne
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (03) : 477 - 479
  • [8] Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review
    Ehsan, Hamid
    Rafae, Abdul
    Masood, Adeel
    Wahab, Ahsan
    Sana, Muhammad Khawar
    Ansar, Iqraa
    Neupane, Karun
    Umar, Arooj
    Ehsan, Amrat
    Hashmi, Hamza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : E285 - E292
  • [9] Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
    Kastritis, E.
    Palladini, G.
    Minnema, M. C.
    Wechalekar, A. D.
    Jaccard, A.
    Lee, H. C.
    Sanchorawala, V
    Gibbs, S.
    Mollee, P.
    Venner, C. P.
    Lu, J.
    Schonland, S.
    Gatt, M. E.
    Suzuki, K.
    Kim, K.
    Cibeira, M. T.
    Beksac, M.
    Libby, E.
    Valent, J.
    Hungria, V
    Wong, S. W.
    Rosenzweig, M.
    Bumma, N.
    Huart, A.
    Dimopoulos, M. A.
    Bhutani, D.
    Waxman, A. J.
    Goodman, S. A.
    Zonder, J. A.
    Lam, S.
    Song, K.
    Hansen, T.
    Manier, S.
    Roeloffzen, W.
    Jamroziak, K.
    Kwok, F.
    Shimazaki, C.
    Kim, J-S
    Crusoe, E.
    Ahmadi, T.
    Tran, N. P.
    Qin, X.
    Vasey, S. Y.
    Tromp, B.
    Schecter, J. M.
    Weiss, B. M.
    Zhuang, S. H.
    Vermeulen, J.
    Merlini, G.
    Comenzo, R. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (01): : 46 - 58
  • [10] Efficacy and safety of intravenous daratumumab-based treatments for AL amyloidosis: a systematic review and meta-analysis
    Sun, Chunyan
    Wang, Xiaohong
    Zhang, Renyi
    Xu, Lingjie
    Wang, Bin
    Li, Jian
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
12345